Aldeyra Therapeutics Inc. (NASDAQ:ALDX)
Old Forum Content for ALDX
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.- Bridget: $ALDX phase 2 pullback after the breakout
- tartan: Bridget just posted on $ALDX I will use the same theory on $ALDX Will buy some as soon as I am finished with this stupid Post
- joelsg1: @Bridget $ALDX 10M share secondary at 12.50.
- bRobert: @Bridget $ALDX I like a. good. pullback. retest. ..........bounce np. $25+. potential.with. nh trigger. Big. WEEKLY. base.
- PJMR11: @geotheo $ALDX Looking to add if it drops to near yesterday's low ($8.61). Decent risk/reward at that level as 20MA and 50MA are $8.36. $8.32.
- geotheo: @PJMR11 $ALDX My thinking here is that I'm going to let it settle out awhile. Got an alert set at $9.60.
- PJMR11: @geotheo $ALDX Have a buy order in at $8.61.
- PJMR11: @geotheo $ALDX Big swings today. Near HOD
- geotheo: @PJMR11 $ALDX Got stopped out of my small position for a loss. I hate to go back. Usually doesn't work out well. If I had not been in I'd sure be looking more closely. Though the stop would be hard. $8.6 a long way from $9.6.
- PJMR11: @geotheo $ALDX I traded this yesterday and today on dips for very nice gains. Still have a core position that I am holding long term. Don't think the last time it was at $12.79 this month is the only time it will ever be at that price. My core position is a bit higher than it is now, but it seems to me that risk/reward here is favorable. I am concerned because we are pushing up on the top Bollinger Band so it may take some time to settle in. The 50 DMA is also more than a buck down, so this requires some baby sitting. I am still a little oversized (I can hear Dan saying don't do that) and will be right sizing if HOD is reached again.
- geotheo: $ALDX Big selloff from the highs yesterday. Understandable. Seems to be really good news on their phase 3 trials. Now hanging around the opening print. Might be an opportunity for a starter position with a stop at 9.
- efrain007: $ALDX watching for a trade
- debeers: $ALDX-Like it bought it. ALDX +55.5% (announces positive results from the Phase 3 ALLEVIATE Trial of 0.25% and 0.5% reproxalap topical ophthalmic solution in patients with allergic conjunctivitis -- trial met primary endpoint and key secondary endpoint for both concentrations of reproxalap)BBBY 19.7% (WSJ reported three activists are trying to replace the entire Board and the CEO; Raymond James also upgraded to Strong Buy this morning)
- lostsheep: @debeers $ALDX watching the 10 level on this pullback
- debeers: $ALDX-Price target info: NASDAQ:ALDX) is Buy with a consensus target price of $23.3333 ... Except of course from Raymondjames who never saw a price target it couldn't raise.... Gee, i'd be happy at 20 LOL..
- PJMR11: $ALDX Added at $10.25
- janner0814: The "Semi Scan" The Semiconductor $SMH group continues to warrant attention (IMO). Rather than going horizontal, I've kept the format vertical; especially since it's post MKT hours (otherwise I'd go horizontal) This group of semis: are solid with both the monthly and weekly charts. $AFOP 0.45% $ALDX 10.09% $AMBA 1.21% $AVGO 3.90% $CAVM 1.33% $CY -1.50% $FSL -0.40% $NXPI -0.29% $SUNE 2.03% $TXN 2.12% Texas Instruments is my proxy for the semis (my #watchlist is only 103 or so) The following semis that look OK on the WKLY chart... meh on the monthlys. $ONNN -0.32% $INTC is in a special category, since it's the long term name associated with the Semis... ok for the covered callers, since the stock is somewhat.... predictable(?... except of late) $INTC 2.31%
Stock Price | $3.27 |
Change | 6.17% |
Volume | 858,342 |
Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.
Request Video of ALDXAlready a member? Sign in here.
Past Month
Leading Peers
-
$11.94 330.09%
-
$14.14 197.10%
-
$9.49 173.74%
Past Month
Lagging Peers
-
$22.90 -51.95%
-
$5.14 -44.74%
-
$7.59 -41.55%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!